Respiratory failure in systemic sclerosis.
Joaquim Ivo Vasques Dantas LandimAndré Silva FrancoPercival Degrava Sampaio-BarrosRenata MiossiAna Cristina de Medeiros RibeiroRosa Maria Rodrigues PereiraAna Paula Luppino AssadPublished in: Rheumatology international (2023)
Systemic sclerosis (SSc) can lead to dyspnea and respiratory failure through multiple mechanisms, making a precise diagnosis particularly challenging, especially amid the current COVID-19 pandemic. In this report, we present a case involving a 26-year-old female who had previously undiagnosed SSc. She experienced acute respiratory failure necessitating orotracheal intubation. Following an extensive evaluation, the patient exhibited skin thickening, kidney failure, thrombocytopenia, microangiopathic anemia, and an antinuclear antibody with a nuclear fine speckled pattern at a titer of 1:320. A diagnosis of SSc complicated by scleroderma renal crisis (SRC) was established. The patient's condition improved after undergoing hemodialysis, receiving an angiotensin-converting enzyme inhibitor, and undergoing cyclophosphamide treatment. Subsequently, she demonstrated sustained improvement during a follow-up period of 20 months.
Keyphrases
- respiratory failure
- systemic sclerosis
- interstitial lung disease
- extracorporeal membrane oxygenation
- angiotensin converting enzyme
- mechanical ventilation
- angiotensin ii
- case report
- cardiac arrest
- public health
- acute respiratory distress syndrome
- tyrosine kinase
- low dose
- air pollution
- intensive care unit
- rheumatoid arthritis
- combination therapy
- iron deficiency
- hepatitis b virus